Clinical Implications of Epigenetic Dysregulation in Perinatal Hypoxic-Ischemic Brain Damage

Placental and fetal hypoxia caused by perinatal hypoxic-ischemic events are major causes of stillbirth, neonatal morbidity, and long-term neurological sequelae among surviving neonates. Brain hypoxia and associated pathological processes such as excitotoxicity, apoptosis, necrosis, and inflammation,...

Full description

Bibliographic Details
Main Authors: Martín Bustelo, Melinda Barkhuizen, Daniel L. A. van den Hove, Harry Wilhelm. M. Steinbusch, Martín A. Bruno, C. Fabián Loidl, Antonio W. Danilo Gavilanes
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.00483/full
_version_ 1811338147452157952
author Martín Bustelo
Martín Bustelo
Martín Bustelo
Martín Bustelo
Melinda Barkhuizen
Daniel L. A. van den Hove
Daniel L. A. van den Hove
Harry Wilhelm. M. Steinbusch
Martín A. Bruno
C. Fabián Loidl
C. Fabián Loidl
Antonio W. Danilo Gavilanes
Antonio W. Danilo Gavilanes
author_facet Martín Bustelo
Martín Bustelo
Martín Bustelo
Martín Bustelo
Melinda Barkhuizen
Daniel L. A. van den Hove
Daniel L. A. van den Hove
Harry Wilhelm. M. Steinbusch
Martín A. Bruno
C. Fabián Loidl
C. Fabián Loidl
Antonio W. Danilo Gavilanes
Antonio W. Danilo Gavilanes
author_sort Martín Bustelo
collection DOAJ
description Placental and fetal hypoxia caused by perinatal hypoxic-ischemic events are major causes of stillbirth, neonatal morbidity, and long-term neurological sequelae among surviving neonates. Brain hypoxia and associated pathological processes such as excitotoxicity, apoptosis, necrosis, and inflammation, are associated with lasting disruptions in epigenetic control of gene expression contributing to neurological dysfunction. Recent studies have pointed to DNA (de)methylation, histone modifications, and non-coding RNAs as crucial components of hypoxic-ischemic encephalopathy (HIE). The understanding of epigenetic dysregulation in HIE is essential in the development of new clinical interventions for perinatal HIE. Here, we summarize our current understanding of epigenetic mechanisms underlying the molecular pathology of HI brain damage and its clinical implications in terms of new diagnostic, prognostic, and therapeutic tools.
first_indexed 2024-04-13T18:05:39Z
format Article
id doaj.art-aa6396ab6215439b8a34900cd1e0986c
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-13T18:05:39Z
publishDate 2020-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-aa6396ab6215439b8a34900cd1e0986c2022-12-22T02:36:04ZengFrontiers Media S.A.Frontiers in Neurology1664-22952020-06-011110.3389/fneur.2020.00483514117Clinical Implications of Epigenetic Dysregulation in Perinatal Hypoxic-Ischemic Brain DamageMartín Bustelo0Martín Bustelo1Martín Bustelo2Martín Bustelo3Melinda Barkhuizen4Daniel L. A. van den Hove5Daniel L. A. van den Hove6Harry Wilhelm. M. Steinbusch7Martín A. Bruno8C. Fabián Loidl9C. Fabián Loidl10Antonio W. Danilo Gavilanes11Antonio W. Danilo Gavilanes12Department of Pediatrics, Maastricht University Medical Center (MUMC), Maastricht, NetherlandsDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, NetherlandsInstituto de Ciencias Biomédicas, Facultad de Ciencias Médicas, Universidad Católica de Cuyo, San Juan, ArgentinaLaboratorio de Neuropatología Experimental, Facultad de Medicina, Instituto de Biología Celular y Neurociencias “Prof. E. De Robertis” (IBCN), Universidad de Buenos Aires, CONICET, Buenos Aires, ArgentinaDepartment of Pediatrics, Maastricht University Medical Center (MUMC), Maastricht, NetherlandsDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, NetherlandsDepartment of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, GermanyDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, NetherlandsInstituto de Ciencias Biomédicas, Facultad de Ciencias Médicas, Universidad Católica de Cuyo, San Juan, ArgentinaInstituto de Ciencias Biomédicas, Facultad de Ciencias Médicas, Universidad Católica de Cuyo, San Juan, ArgentinaLaboratorio de Neuropatología Experimental, Facultad de Medicina, Instituto de Biología Celular y Neurociencias “Prof. E. De Robertis” (IBCN), Universidad de Buenos Aires, CONICET, Buenos Aires, ArgentinaDepartment of Pediatrics, Maastricht University Medical Center (MUMC), Maastricht, NetherlandsFacultad de Ciencias Médicas, Instituto de Investigación e Innovación de Salud Integral, Universidad Católica de Santiago de Guayaquil, Guayaquil, EcuadorPlacental and fetal hypoxia caused by perinatal hypoxic-ischemic events are major causes of stillbirth, neonatal morbidity, and long-term neurological sequelae among surviving neonates. Brain hypoxia and associated pathological processes such as excitotoxicity, apoptosis, necrosis, and inflammation, are associated with lasting disruptions in epigenetic control of gene expression contributing to neurological dysfunction. Recent studies have pointed to DNA (de)methylation, histone modifications, and non-coding RNAs as crucial components of hypoxic-ischemic encephalopathy (HIE). The understanding of epigenetic dysregulation in HIE is essential in the development of new clinical interventions for perinatal HIE. Here, we summarize our current understanding of epigenetic mechanisms underlying the molecular pathology of HI brain damage and its clinical implications in terms of new diagnostic, prognostic, and therapeutic tools.https://www.frontiersin.org/article/10.3389/fneur.2020.00483/fullhypoxic-ischemic encephalopathybiomarkerhypoxiaischemiamicroRNAshistone modifications
spellingShingle Martín Bustelo
Martín Bustelo
Martín Bustelo
Martín Bustelo
Melinda Barkhuizen
Daniel L. A. van den Hove
Daniel L. A. van den Hove
Harry Wilhelm. M. Steinbusch
Martín A. Bruno
C. Fabián Loidl
C. Fabián Loidl
Antonio W. Danilo Gavilanes
Antonio W. Danilo Gavilanes
Clinical Implications of Epigenetic Dysregulation in Perinatal Hypoxic-Ischemic Brain Damage
Frontiers in Neurology
hypoxic-ischemic encephalopathy
biomarker
hypoxia
ischemia
microRNAs
histone modifications
title Clinical Implications of Epigenetic Dysregulation in Perinatal Hypoxic-Ischemic Brain Damage
title_full Clinical Implications of Epigenetic Dysregulation in Perinatal Hypoxic-Ischemic Brain Damage
title_fullStr Clinical Implications of Epigenetic Dysregulation in Perinatal Hypoxic-Ischemic Brain Damage
title_full_unstemmed Clinical Implications of Epigenetic Dysregulation in Perinatal Hypoxic-Ischemic Brain Damage
title_short Clinical Implications of Epigenetic Dysregulation in Perinatal Hypoxic-Ischemic Brain Damage
title_sort clinical implications of epigenetic dysregulation in perinatal hypoxic ischemic brain damage
topic hypoxic-ischemic encephalopathy
biomarker
hypoxia
ischemia
microRNAs
histone modifications
url https://www.frontiersin.org/article/10.3389/fneur.2020.00483/full
work_keys_str_mv AT martinbustelo clinicalimplicationsofepigeneticdysregulationinperinatalhypoxicischemicbraindamage
AT martinbustelo clinicalimplicationsofepigeneticdysregulationinperinatalhypoxicischemicbraindamage
AT martinbustelo clinicalimplicationsofepigeneticdysregulationinperinatalhypoxicischemicbraindamage
AT martinbustelo clinicalimplicationsofepigeneticdysregulationinperinatalhypoxicischemicbraindamage
AT melindabarkhuizen clinicalimplicationsofepigeneticdysregulationinperinatalhypoxicischemicbraindamage
AT daniellavandenhove clinicalimplicationsofepigeneticdysregulationinperinatalhypoxicischemicbraindamage
AT daniellavandenhove clinicalimplicationsofepigeneticdysregulationinperinatalhypoxicischemicbraindamage
AT harrywilhelmmsteinbusch clinicalimplicationsofepigeneticdysregulationinperinatalhypoxicischemicbraindamage
AT martinabruno clinicalimplicationsofepigeneticdysregulationinperinatalhypoxicischemicbraindamage
AT cfabianloidl clinicalimplicationsofepigeneticdysregulationinperinatalhypoxicischemicbraindamage
AT cfabianloidl clinicalimplicationsofepigeneticdysregulationinperinatalhypoxicischemicbraindamage
AT antoniowdanilogavilanes clinicalimplicationsofepigeneticdysregulationinperinatalhypoxicischemicbraindamage
AT antoniowdanilogavilanes clinicalimplicationsofepigeneticdysregulationinperinatalhypoxicischemicbraindamage